Advancing Life Science Construction 2026

Advancing Life Science Construction 2026 convened the developers, owners, designers, and builders shaping the next generation of US life science facilities, at a moment when the sector was decisively re-accelerating.

As therapies move from discovery to commercialization faster than ever, life science projects face unprecedented pressure: compressed timelines, evolving GMP and regulatory expectations, capital discipline, and the need to design facilities that remain flexible in an uncertain pipeline environment. Across the US, renewed investment in labs and biomanufacturing is demanding smarter delivery models, earlier collaboration, and greater certainty from concept to commissioning.

This was the must-attend forum to hear directly from industry leaders on how they are accelerating delivery, de-risking complex builds, and futureproofing facilities to support the next wave of life science innovation.